A/Prof. Steven Rockman
Honorary
Microbiology and Immunology
20 Scholarly works
4 Projects
HIGHLIGHTS
2021
Research Grant
Accelerated phase I trial of targeted and tunable SARS-Cov-2 spike protein receptor binding domain recombinant protein and mRNA vaccines
2020
Journal article
New Technologies for Influenza Vaccines
DOI: 10.3390/microorganisms81117452020
Research Grant
A safe, effective, and rapidly tuneable SARS-CoV-2 vaccine
2020
Journal article
Pandemic Influenza Vaccines: What did We Learn from the 2009 Pandemic and are We Better Prepared Now?
DOI: 10.3390/vaccines80202112020
Journal article
Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial
DOI: 10.1371/journal.pmed.10030242019
Journal article
The structure of the influenza A virus genome
DOI: 10.1038/s41564-019-0513-72019
Journal article
Insights into the Acquisition of Virulence of Avian Influenza Viruses during a Single Passage in Ferrets
DOI: 10.3390/v11100915
RECENT SCHOLARLY WORKS
2019
Journal article
Downregulation of MHC Class I Expression by Influenza A and B Viruses
DOI: 10.3389/fimmu.2019.011582019
Journal article
Human CD8( ) T cell cross-reactivity across influenza A, B and C viruses
DOI: 10.1038/s41590-019-0320-62018
Journal article
Nitrogen deprivation in Fusarium oxysporum promotes mycotoxin production via intermediates in the Krebs cycle and unreported methylmalonyl-CoA mutase activity.
DOI: 10.1007/s11306-018-1459-02018
Journal article
Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection
DOI: 10.1093/infdis/jiy3282018
Journal article
Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch (TM))
DOI: 10.1016/j.vaccine.2018.05.053
RECENT PROJECTS
2021
Research Grant
Accelerated phase I trial of targeted and tunable SARS-Cov-2 spike protein receptor binding domain recombinant protein and mRNA vaccines
2021
Research Grant
Accelerated phase I trial of targeted and tunable SARS-Cov-2 spike protein receptor binding domain recombinant protein and mRNA vaccines